{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T21:38:58Z","timestamp":1788212338075,"version":"build-2803163510"},"reference-count":31,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Italian Ministry of Health with Ricerca Corrente and 5x1000 funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: The molecular concordance between primary lung adenocarcinoma and metastatic lesions remains incompletely characterized despite its direct implications for precision oncology and biopsy-driven therapeutic decision-making. This prospective monocentric paired-sample study evaluated genomic concordance between primary lung adenocarcinoma and synchronous thoracic metastatic lesions using targeted next-generation sequencing (NGS). Methods: We identified 27 treatment-na\u00efve patients with histologically confirmed lung adenocarcinoma who underwent paired molecular profiling of the primary tumor and a synchronous thoracic metastatic site (pleural or intrapulmonary). DNA and RNA were analyzed using validated institutional NGS platforms. Genomic alterations, including clinically actionable oncogenic drivers consistently covered by the sequencing panel used in each pair, were compared across matched samples. Concordance was assessed using exact binomial confidence intervals, Cohen\u2019s \u03ba statistics, McNemar tests, and paired Wilcoxon signed-rank tests. Results: Actionable driver alterations were identified in 17 of 27 patients (63.0%; 95% CI 42.4\u201380.6), including EGFR mutations (40.7%), KRAS alterations (18.5%), and one ALK gene rearrangement (3.7%). TP53 concurrent mutations were detected in 14 cases (51.9%). Across all 27 paired samples, driver-level concordance was 100% (95% CI 87.2\u2013100), with perfect agreement for EGFR, KRAS, and ALK alterations (\u03ba = 1.00). TP53 mutations showed high concordance (92.9%; \u03ba = 0.85), while CNVs were concordant in 88.0% of evaluable pairs. Variant allele frequency (VAF) comparisons, adjusted for tumor cellularity, further supported the apparent clonal stability of driver alterations across paired samples. Conclusions: This study demonstrates very high molecular concordance between primary lung adenocarcinomas and their synchronous pleural or intrapulmonary metastases. The observed 100% concordance of actionable driver alterations across paired specimens supports the clinical reliability of thoracic metastatic biopsies for baseline molecular profiling in treatment-na\u00efve disease. Although limited by sample size, these findings support the biological stability of actionable driver alterations during early thoracic metastatic dissemination.<\/jats:p>","DOI":"10.3390\/cancers18111773","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:06:56Z","timestamp":1780049216000},"page":"1773","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Concordance of Actionable Driver Alterations Between Primary Lung Adenocarcinoma and Paired Thoracic Metastases: A Prospective Next-Generation Sequencing Study"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1153-3334","authenticated-orcid":false,"given":"Luca","family":"Bertolaccini","sequence":"first","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9\/1, 20122 Milan, Italy"},{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Lombardi","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Chiari","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9180-4757","authenticated-orcid":false,"given":"Alessandra","family":"Rappa","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-7811","authenticated-orcid":false,"given":"Monica","family":"Casiraghi","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9\/1, 20122 Milan, Italy"},{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"D\u2019Ercole","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5330-5495","authenticated-orcid":false,"given":"Antonio","family":"Mazzella","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2629-7781","authenticated-orcid":false,"given":"Giorgio","family":"Lo Iacono","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3157-3720","authenticated-orcid":false,"given":"Shehab","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Midolo De Luca","sequence":"additional","affiliation":[{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9101-9131","authenticated-orcid":false,"given":"Nicola","family":"Fusco","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9\/1, 20122 Milan, Italy"},{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Guerini Rocco","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9\/1, 20122 Milan, Italy"},{"name":"Division of Pathology, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spaggiari","sequence":"additional","affiliation":[{"name":"Department of Oncology and Hemato-Oncology, University of Milan, Via Santa Sofia 9\/1, 20122 Milan, Italy"},{"name":"Department of Thoracic Surgery, IEO, European Institute of Oncology IRCCS, Via Ripamonti 435, 20141 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Grigoriadou, G.\u0399., Esagian, S.M., Ryu, H.S., and Nikas, I.P. (2020). Molecular Profiling of Malignant Pleural Effusions with Next Generation Sequencing (NGS): Evidence that Supports Its Role in Cancer Management. J. Pers. Med., 10.","DOI":"10.3390\/jpm10040206"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1179554920947335","DOI":"10.1177\/1179554920947335","article-title":"Genetic Heterogeneity Between Paired Primary and Brain Metastases in Lung Adenocarcinoma","volume":"14","author":"Liu","year":"2020","journal-title":"Clin. Med. Insights Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41586-023-05729-x","article-title":"The evolution of non-small cell lung cancer metastases in TRACERx","volume":"616","author":"Huebner","year":"2023","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature22364","article-title":"Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution","volume":"545","author":"Abbosh","year":"2017","journal-title":"Nature"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1097\/JTO.0000000000000487","article-title":"High Discrepancy of Driver Mutations in Patients with NSCLC and Synchronous Multiple Lung Ground-Glass Nodules","volume":"10","author":"Wu","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/14737140.2025.2601769","article-title":"Genomic divergence between matched primary and metastatic tumors across cancer types: A pan-cancer analysis of 5692 samples","volume":"26","author":"Ergun","year":"2026","journal-title":"Expert Rev. Anticancer. Ther."},{"key":"ref_7","first-page":"507","article-title":"Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis","volume":"30","author":"Tian","year":"2023","journal-title":"Cancer Gene Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/s41568-024-00734-2","article-title":"The evolutionary theory of cancer: Challenges and potential solutions","volume":"24","author":"Laplane","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Lojo-Rodr\u00edguez, I., Botana-Rial, M., Gonz\u00e1lez-Montaos, A., Leiro-Fern\u00e1ndez, V., Gonz\u00e1lez-Pi\u00f1eiro, A., Ramos-Hern\u00e1ndez, C., and Fern\u00e1ndez-Villar, A. (2024). Clinical and Molecular Features of Malignant Pleural Effusion in Non-Small Cell Lung Cancer (NSCLC) of a Caucasian Population. Medicina, 60.","DOI":"10.3390\/medicina60111804"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Ren, W., Zhu, Y., Wang, Q., Jin, H., Guo, Y., and Lin, D. (2023). Deep Learning-Based Classification and Targeted Gene Alteration Prediction from Pleural Effusion Cell Block Whole-Slide Images. Cancers, 15.","DOI":"10.3390\/cancers15030752"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"8715","DOI":"10.21037\/jtd-2025-1511","article-title":"Characterization of pleural metastasis in non-small cell carcinomas undergoing intraoperative frozen section examination","volume":"17","author":"Park","year":"2025","journal-title":"J. Thorac. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Mazzella, A., Degiovanni, S., Mariani, E., Cerretani, G., Bertolaccini, L., Casiraghi, M., Sedda, G., Iacono, G.L., and Spaggiari, L. (2026). Safety and Efficacy of Single-Stage Synchronous Bilateral VATS Talc Poudrage for Malignant Pleural Effusion. Cancers, 18.","DOI":"10.3390\/cancers18111676"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102283","DOI":"10.1016\/j.eclinm.2023.102283","article-title":"A framework for the definition and interpretation of the use of surrogate endpoints in interventional trials","volume":"65","author":"Ciani","year":"2023","journal-title":"eClinicalMedicine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7529","DOI":"10.1200\/jco.2012.30.15_suppl.7529","article-title":"Concordance of driver mutations in primary and matched metastasis from patients with non-small cell lung cancer (NSCLC) using next-generation sequencing (NGS)","volume":"30","author":"Vignot","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.21037\/jtd.2016.03.96","article-title":"High concordance of ALK rearrangement between primary tumor and paired metastatic lymph node in patients with lung adenocarcinoma","volume":"8","author":"Hou","year":"2016","journal-title":"J. Thorac. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.7150\/jca.28266","article-title":"A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer","volume":"10","author":"Chen","year":"2019","journal-title":"J. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13046-015-0207-9","article-title":"Mutation status concordance between primary lesions and metastatic sites of advanced non-small-cell lung cancer and the impact of mutation testing methodologies: A literature review","volume":"34","author":"Sherwood","year":"2015","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lungcan.2005.01.001","article-title":"International Association for the Study of Lung Cancer Staging C. Complete resection in lung cancer surgery: Proposed definition","volume":"49","author":"Wittekind","year":"2005","journal-title":"Lung Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1159\/000503095","article-title":"Performance Status Assessment by Using ECOG (Eastern Cooperative Oncology Group) Score for Cancer Patients by Oncology Healthcare Professionals","volume":"12","author":"Azam","year":"2019","journal-title":"Case Rep. Oncol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.jtho.2023.01.088","article-title":"IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer","volume":"18","author":"Asamura","year":"2023","journal-title":"J. Thorac. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","article-title":"Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology","volume":"142","author":"Lindeman","year":"2018","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_22","unstructured":"Team R (2021). RStudio: Integrated Development Environment for R, RStudio, Inc."},{"key":"ref_23","unstructured":"R Core Team (2021). R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/s41586-023-05776-4","article-title":"Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA","volume":"616","author":"Abbosh","year":"2023","journal-title":"Nature"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","article-title":"Tracking the Evolution of Non\u2013Small-Cell Lung Cancer","volume":"376","author":"Wilson","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.18632\/oncotarget.27837","article-title":"Comparative genomic analysis of primary tumors and paired brain metastases in lung cancer patients by whole exome sequencing: A pilot study","volume":"11","author":"Tomasini","year":"2020","journal-title":"Oncotarget"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s13402-012-0078-4","article-title":"EGFR and KRAS mutations in lung carcinomas in the Dutch population: Increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma","volume":"35","author":"Smits","year":"2012","journal-title":"Cell. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1183\/09031936.00167407","article-title":"Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma","volume":"32","author":"Wu","year":"2008","journal-title":"Eur. Respir. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1126\/science.1253462","article-title":"Spatial and temporal diversity in genomic instability processes defines lung cancer evolution","volume":"346","author":"McGranahan","year":"2014","journal-title":"Science"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A Modified Poisson Regression Approach to Prospective Studies with Binary Data","volume":"159","author":"Zou","year":"2004","journal-title":"Am. J. Epidemiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e57183","DOI":"10.2196\/57183","article-title":"Outcomes of Patients With Early and Locally Advanced Lung Cancer: Protocol for the Italian Lung Cancer Observational Study (LUCENT)","volume":"13","author":"Bertolaccini","year":"2024","journal-title":"JMIR Res. Protoc."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1773\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:12:04Z","timestamp":1780049524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/11\/1773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":31,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["cancers18111773"],"URL":"https:\/\/doi.org\/10.3390\/cancers18111773","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]}}}